Analystreport

Adamis Pharmaceuticals Co. (NASDAQ: ADMP) had its price target raised by analysts at Maxim Group from $5.00 to $10.00. They now have a "buy" rating on the stock.

Adamis Pharmaceuticals Corporation  (ADMP) 
Last adamis pharmaceuticals corporation earnings: 11/12 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamispharmaceuticals.com/investor-overview